“Overall, it will help manufacturers bring their innovations to market more efficiently by providing a transparent process for future submissions and making sure our regulatory approach is properly tailored to the unique opportunities and challenges posed by this promising new technology,” explained FDA Commissioner Scott Gottlieb, MD.
Replacing devices based on 19th-century technology* and still in use, Cornell University engineers have developed a simple method for gathering blood pressure, heart rate, and breath rate from multiple patients simultaneously. It uses low-power radio-frequency signals and low-cost microchip radio-frequency identification (RFID) “tags” -- similar to the ubiquitous anti-theft tags used in department stores.
The general public is aware of the well documented dangers of tobacco products, drugs, and alcohol, but what about cell phones? That was the central question at the screening and discussion of the documentary, “Generation Zapped,” at the Shrewsbury Public Library on Thursday, December 7. The event was held by Wireless Education, a non-profit dedicated to providing information to parents and consumers so they can make conscious decisions about how they use WiFi technology.
Scientists from SRI International and Collaborations Pharmaceuticals in the US have identified a potential new inhibitor, tilorone dihydrochloride, for infection by Ebola virus. The researchers used machine learning methods to find the immunomodulatory drug, which is reported to have demonstrated significant efficacy with 100% survival in a disease model of the virus.
The world’s most valuable company crammed a lot into the tablespoon-sized volume of an Apple Watch. There’s GPS, a heart-rate sensor, cellular connectivity, and computing resources that not long ago would have filled a desk-dwelling beige box. The wonder gadget doesn’t have a sphygmomanometer for measuring blood pressure or polysomnographic equipment found in a sleep lab—but thanks to machine learning, it might be able to help with their work.
Immunotherapy for leukemia patients has been nothing short of a miracle. Now scientists hope to use that science and other forms of gene therapy to tackle three of the deadliest forms of cancer: glioblastoma (brain cancer), sarcoma (bone cancer) and ovarian cancer. Three scientists have received $1.3 million in critical funding from the Alliance for Cancer Gene Therapy (ACGT), the nation's only nonprofit dedicated exclusively to cell and gene therapies for cancer.
Transparent biosensors embedded into contact lenses could soon allow doctors and patients to monitor blood glucose levels and a host of other telltale signs of disease without invasive tests.
Carnegie Mellon scientists are creating cutting-edge technology that could one day solve the shortage of heart transplants, which are currently needed to repair damaged organs. "We’ve been able to take MRI images of coronary arteries and 3-D images of embryonic hearts and 3-D bioprint them with unprecedented resolution and quality out of very soft materials like collagens, alginates and fibrins," said Adam Feinberg, an associate professor of Materials Science and Engineering and Biomedical Engineering at Carnegie Mellon University.
For an advanced economy such as the United States, innovation is a wellspring of economic growth and a powerful tool for addressing our most pressing challenges as a nation – such as enabling more Americans to lead longer, healthier lives, and accelerating the transition to a low-carbon economy. In fact, from 1948-2012 over half of the total increase in U.S. productivity growth, a key driver of economic growth, came from innovation and technological change.
A new world of flexible, bendable, even stretchable electronics is emerging from research labs to address a wide range of potentially game-changing uses. The common, rigid printed circuit board is slowly being replaced by a thin ribbon of resilient, high-performance electronics.